艾叶艾灸治疗类风湿关节炎动物模型的荟萃分析:临床疗效与炎症小体及细胞因子信号机制的关联
结果显示艾灸显著降低关节炎指数、足爪体积和组织病理学评分,并下调促炎细胞因子及NF-κB、NLRP3、TLR4、MyD88等信号通路,为艾灸作为RA辅助治疗的临床研究提供了临床前证据。
要点
- 艾灸显著减轻RA动物模型的关节炎严重程度和组织病理损伤。
- 艾灸降低IL-1β、IL-6、TNF-α水平并抑制NF-κB、NLRP3等通路。
- 结果为临床前证据,支持未来开展艾灸辅助治疗RA的临床研究。
核心结论
- 艾灸可减轻RA动物模型的关节炎严重程度和组织病理学损伤,可能通过调节炎症网络和抑制NF-κB、NLRP3等关键通路发挥作用。
主要发现
- 艾灸显著降低关节炎指数(SMD -3.72,95% CI -4.25至-3.20)、足爪体积(SMD -4.59,95% CI -5.54至-3.63)和组织病理学评分(SMD -2.24,95% CI -2.80至-1.67)。
- 艾灸降低IL-1β(SMD -3.52,95% CI -4.19至-2.86)、IL-6(SMD -3.17,95% CI -4.17至-2.16)和TNF-α(SMD -3.38,95% CI -3.97至-2.79)水平。
- 艾灸抑制NF-κB(SMD -2.29,95% CI -3.20至-1.37)、NLRP3(SMD -1.74,95% CI -2.49至-0.99)、TLR4(SMD -6.72,95% CI -12.54至-0.90)和MyD88(SMD -9.16,95% CI -15.28至-3.04)信号蛋白。
临床怎么用
- 为艾灸作为RA潜在辅助疗法提供临床前证据,提示可考虑未来开展临床研究验证其疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Moxibustion, a traditional Chinese healing method, uses mugwort (Artemisia argyi H.Lév. & Vaniot) to apply heat to specific points, treating conditions like "Bi Zheng", which is akin to rheumatoid arthritis (RA). According to traditional theory, its therapeutic actions are attributed to warming the meridians and regulating the flow of Qi and blood. AIM OF THE STUDY: To quantitatively evaluate the therapeutic efficacy of moxibustion and to map its anti-arthritic mechanisms in animal models of RA. MATERIALS AND METHODS: The protocol was registered with PROSPERO (CRD42024503829) and reported according to PRISMA 2020. Eight databases were searched through 28 July 2025 for randomized controlled animal studies comparing moxibustion with the control in RA models. The primary outcome was arthritis severity, assessed by the arthritis index, paw volume, and histopathological score. Secondary endpoints included serum or tissue levels of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), immunomodulatory cytokines (IL-10, IL-4), and key signaling proteins (NF-κB, NLRP3, TLR4, MyD88). The SYRCLE tool was used to assess the risk of bias. RESULTS: Seventy-three studies were included. Meta-analysis showed that moxibustion significantly reduced arthritis severity (arthritis index: SMD -3.72, 95% CI -4.25 to -3.20; paw volume: SMD -4.59, 95% CI -5.54 to -3.63; histopathological score: SMD -2.24, 95% CI -2.80 to -1.67). Moxibustion also lowered the levels of pro-inflammatory cytokines: IL-1β (SMD -3.52, 95% CI -4.19 to -2.86), IL-6 (SMD -3.17, -4.17 to -2.16), and TNF-α (SMD -3.38, -3.97 to -2.79) and suppressed key signaling pathways, including NF-κB (SMD -2.29, 95% CI -3.20 to -1.37), NLRP3 (SMD -1.74, 95% CI -2.49 to -0.99), TLR4 (SMD -6.72, 95% CI -12.54 to -0.90), and MyD88 (SMD -9.16, 95% CI -15.28 to -3.04). CONCLUSION: This meta-analysis suggests that moxibustion alleviates arthritis severity and histopathological damage in RA animal models, potentially through modulating inflammatory networks and inhibiting key pathways such as NF-κB and NLRP3. These findings provide preclinical evidence supporting the rationale for future clinical investigation of moxibustion as a potential adjunct therapy for RA.
引用
- Ma J, Zhao Y, Liu S, et al. Moxibustion with Artemisia argyi H.Lév. & Vaniot in rheumatoid arthritis animal models: A meta-analysis linking clinical efficacy to inflammasome and cytokine signaling mechanisms. J Ethnopharmacol. 2026. PMID: 41638452. doi:10.1016/j.jep.2026.121302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。